It’s Time For Congress To Get 340B Out Of Its Blind Spot
If a charity organization collected billions of dollars with little evidence that needy people benefited, regulators and the public would quickly demand answers. Yet many large hospital systems participating in the federal 340B Drug Pricing Program…
